Ganaxolone for treating intractable infantile spasms: a multicenter, open-label, add-on trial. (Q51372905)

4 April 2018

http://europepmc.org/abstract/MED/11074186

title

Ganaxolone for treating intractable infantile spasms: a multicenter, open-label, add-on trial. (English)

1 reference

4 April 2018

http://europepmc.org/abstract/MED/11074186

main subject

multicenter clinical trial

1 reference

Kerrigan JF

1

1 reference

4 April 2018

http://europepmc.org/abstract/MED/11074186

Shields WD

2

1 reference

4 April 2018

http://europepmc.org/abstract/MED/11074186

Nelson TY

3

1 reference

4 April 2018

http://europepmc.org/abstract/MED/11074186

Bluestone DL

4

1 reference

4 April 2018

http://europepmc.org/abstract/MED/11074186

Dodson WE

5

1 reference

4 April 2018

http://europepmc.org/abstract/MED/11074186

Bourgeois BF

6

1 reference

4 April 2018

http://europepmc.org/abstract/MED/11074186

Pellock JM

7

1 reference

4 April 2018

http://europepmc.org/abstract/MED/11074186

Morton LD

8

1 reference

4 April 2018

http://europepmc.org/abstract/MED/11074186

Monaghan EP

9

1 reference

4 April 2018

http://europepmc.org/abstract/MED/11074186

publication date

1 December 2000

1 reference

4 April 2018

http://europepmc.org/abstract/MED/11074186

published in

Epilepsy Research

1 reference

4 April 2018

http://europepmc.org/abstract/MED/11074186

volume

42

1 reference

4 April 2018

http://europepmc.org/abstract/MED/11074186

issue

2-3

1 reference

4 April 2018

http://europepmc.org/abstract/MED/11074186

page(s)

133-139

1 reference

4 April 2018

http://europepmc.org/abstract/MED/11074186

cites work

Vigabatrin as initial therapy for infantile spasms: a European retrospective survey. Sabril IS Investigator and Peer Review Groups

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2800%2900170-4

7 January 2021

Anticonvulsant profile of the progesterone metabolite 5 alpha-pregnan-3 alpha-ol-20-one

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2800%2900170-4

7 January 2021

Proposal for revised classification of epilepsies and epileptic syndromes. Commission on Classification and Terminology of the International League Against Epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2800%2900170-4

7 January 2021

Severe persistent visual field constriction associated with vigabatrin

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2800%2900170-4

7 January 2021

Hypsarrhythmia: variations on the theme

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2800%2900170-4

7 January 2021

High-dose, long-duration versus low-dose, short-duration corticotropin therapy for infantile spasms

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2800%2900170-4

7 January 2021

Long-term prognosis in infantile spasms: a follow-up report on 112 cases.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2800%2900170-4

7 January 2021

Vigabatrin-associated retinal cone system dysfunction: electroretinogram and ophthalmologic findings

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2800%2900170-4

7 January 2021

Treatment of infantile spasms with high-dose ACTH: efficacy and plasma levels of ACTH and cortisol

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2800%2900170-4

7 January 2021

Epileptic spasms in older children: persistence beyond infancy

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2800%2900170-4

7 January 2021

10.1016/S0920-1211(00)00170-4

Identifiers

DOI

1 reference

4 April 2018

http://europepmc.org/abstract/MED/11074186

1 reference

4 April 2018